GPT Healthcare (GPTHEALTH.NS) Stock Price

GPT Healthcare Price

CLOSED
139.62
​
Market closed

Over the last 10 years GPT Healthcare grew revenue by 15.0% annually, reaching 4.73 B INR. Earnings per share have grown at 38.4% per year over the last 10 years. For GPT Healthcare, the net margin of 8.9% is down versus 12.4% a few years ago. At today's price the dividend yield works out to roughly 1.79%. The payout ratio is around 49% of earnings. The consensus 12-month price target for GPT Healthcare is 138.72 INR, about 0.6% below where the stock trades today. Of 5 analysts, 4 rate the stock a buy — an overall Buy consensus.

GPT Healthcare stock price

Access this data via the Eulerpool API

GPT Healthcare business model & stock analysis

GPT Healthcare Ltd is a IN-based company operating in Health Care Providers & Services industry. The company is headquartered in Kolkata, West Bengal and currently employs 1,902 full-time employees. The company went IPO on 2024-02-29. GPT Healthcare Limited is an India-based company. The Company’s principal activities include the operation of multidisciplinary private hospitals and pharmacies. The company has four multispecialty hospitals, two in Kolkata, Salt Lake, one in Agartala and one hospital in Howrah, West Bengal, and has one nursing institute in Agartala, under the brand name ILS Hospitals. ILS Hospitals, Agartala is a 205 bedded multispecialty hospital with a 50 Seat BSc Nursing College. ILS Hospitals, Agartala has eight operating theaters, one catheterization laboratory and other diagnostic and therapeutic equipment. The ILS Hospitals Dumdum is a six-storied, 155 bedded multispecialty hospital. ILS Hospitals Dumdum has four operation theaters, one catheterization laboratory and other diagnostic and therapeutic equipment. ILS Hospitals Howrah is a multi-specialty hospital, which is equipped with 116 beds. ILS Hospitals Salt Lake is a renowned multispecialty hospital with 85 beds and three operation theaters.

Frequently asked questions about GPT Healthcare

Analysts currently set an average price target of 138.72 INR for the GPT Healthcare stock (median: 138.72 INR), implying -0.6 % versus the latest price. The consensus is based on 5 analyst ratings.

5 analysts currently rate the GPT Healthcare stock: 4 recommend buying, 1 holding and 0 selling. For 2026, analysts expect GPT Healthcare to generate revenue of 4.68 B INR and earnings per share of 4.60 INR.

Converted at the current exchange rate, the GPT Healthcare share trades at 1.29 EUR (139.62 INR).

The expected revenue of GPT Healthcare is 4.68 B INR. This figure is based on current financial data and reflects the company's business performance.

The expected profit of GPT Healthcare is 377.43 M INR. The net profit reflects the company's profitability after deducting all expenses.

The price-to-earnings ratio (P/E) of GPT Healthcare is currently 30.35. The P/E ratio compares the current share price to the earnings per share and helps investors assess the valuation of the GPT Healthcare stock.

The price-to-sales ratio (P/S) of GPT Healthcare is currently 2.45. The P/S ratio compares the market capitalization to the annual revenue and serves as a valuation metric for the GPT Healthcare stock.

The Eulerpool Quality Score for GPT Healthcare is 5/10.

The ISIN of GPT Healthcare is INE486R01017. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.

The ticker of GPT Healthcare is GPTHEALTH.NS. The ticker symbol is used to trade GPT Healthcare shares on the stock exchange.

Fair ValueTerminal
136.83 INR
Over-/UndervaluationTerminal
Fairly valued
Sector
Industry
Health Care Providers & Services
Number of shares
Employees
Revenue per Employee
2.48 M INR
Revenue growth Ø5 years
EBIT growth Ø5 years
Net Income growth Ø5 years
Country
Currency
INR
Initial public offering
Feb 29, 2024
ISIN
INE486R01017
Cusip
Y2842E100
Market capitalization
11.46 B INRLarge Cap
52-Week Range
PEG
1.27
P/E ratio
P/Ee 2026
30.35
P/Ee 2026
18.13
P/Ee 2027
13.96
P/Ee 2028
13.96
P/S
P/Se
2.45
EV/EBIT
21.58
P/B Ratio
4.25
ROE (Return on Equity)
ROA (Return on Assets)
ROCE (Return on Capital Employed)
ROIC (Return on Invested Capital)
11.71 %
Dividend
Dividend yield
1.79 %
Est. Dividend Yield
1.79 %
Payout Ratio
48.59 %
Dividend growth Ø5Y
—
Dividend payments per year
2
Dividend paid since
2 years
Dividend not reduced since
0 years
Dividend increased since
0 years
Dividend withholding tax
20.00 %
Last updated Oct 11, 2026, 4:13 AM

GPT Healthcare Peer Group